From Financial Modeling Prep: 2024-12-12 12:13:00

UiPath (NYSE:PATH) shares dropped 2% after UBS gave a Sell rating with a $14 price target. Competition, slow customer growth, and weak performance metrics were cited as concerns.

Competition from tech giants and AI startups has hindered UiPath’s customer growth since late 2022, coinciding with the launch of ChatGPT.

Customer retention remains a challenge, despite organizational changes. Doubts linger about UiPath’s ability to regain momentum in the market.

UBS projected a decline in net new ARR for UiPath in 2025 and 2026, falling short of Wall Street expectations for growth in those years. Customers and partners show lukewarm enthusiasm for RPA market growth.



Read more at Financial Modeling Prep:: UBS Initiates Coverage on UiPath with Sell Rating,…